Skip to main content

Diabetes Drug News

Diabetes Drugs are responsible for helping to decrease blood sugar levels so that you can try to stay in a healthier range and help avoid serious complications.

Metformin     Insulin     SGLT-2     GLP-1     DPP-4     Combo drugs     Sulfonylureas     TZDs

Closed loop systems, stem cells, smart insulin, and more!
Today, Lilly/BI announced first-ever news in diabetes: a major clinical trial on Jardiance , an SGLT-2 inhibitor pill for type 2 diabetes, has been proven to improve...
Praluent now approved for two specific patient populations. How this drug has the future potential to make a big impact on people with diabetes.
And “potentially transformative” advances coming for type 1 diabetes.
Zosano Pharma is making early progress with an innovative patch-based glucagon delivery system for severe hypoglycemia, recently announcing that it has completed...
Currently recruiting in people newly diagnosed with type 1.
What did four diabetes experts say was the most promising future innovation in diabetes?
What a ride! This year the American Diabetes Association’s (ADA) 75 th Scientific Sessions included groundbreaking clinical trial results, the latest updates on diabetes...
One of the biggest drug highlights at the 2015 ADA Scientific Sessions was a compelling presentation by diaTribe scientific Advisory Board member Dr. John Buse on brand...
By Kelly Close Twitter Summary: @kellyclose speaks to @US_FDA in favor of PCSK9 inhibitor drug Praluent – need to bring more options to #PWD to fight against CV disease...
Kicking off this weekend, what are we most excited about for this year’s ADA?
Lilly announced that the FDA has approved its Humalog 200 units/mL KwikPen (insulin lispro) for type 1 and type 2 diabetes, making it the first concentrated mealtime...
The symptoms, who is at risk, and what every patient on SGLT-2 inhibitors can do right now.
How fast are insulin prices actually rising? Why might this be happening, and what is the impact on patients with varying levels of health care coverage?
How a new trial is testing a novel pill for blood glucose management – currently enrolling!
$300 million and counting – how much have we learned from the heart safety trials of Onglyza and Nesina?
After the rapid-acting inhaled insulin Afrezza launched this February, we have been very eager to learn more about how this new product impacts patients’ day-to-day...
Another diabetes drug that helps people lose weight?
Over seven million Americans have diabetic retinopathy – how Eylea provides another treatment for this serious complication.
Dr. Doug Melton and colleagues at the Harvard Stem Cell Institute recently announced new partnerships with Novartis and AstraZeneca to advance stem cell research for...

Pages